Home › Companies › ALNYLAM PHARMACEUTICALS INC. › 2023-2024
Compiled from SEC Form N-PX filings and ALNYLAM PHARMACEUTICALS INC.’s Form 8-K, filed 2024-05-20 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore ALNYLAM PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are ALNYLAM PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-05-20 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Dennis A. Ausiello, M.D. | 103,971,532 | 8,960,235 | 14,285 | -- | 4,991,057 | Majority: yes |
| Elect Director: Olivier Brandicourt, M.D. | 106,444,201 | 6,487,472 | 14,379 | -- | 4,991,057 | Majority: yes |
| Elect Director: Peter N. Kellogg | 108,577,015 | 4,354,577 | 14,460 | -- | 4,991,057 | Majority: yes |
| Elect Director: David E.I. Pyott | 102,273,209 | 10,658,278 | 14,565 | -- | 4,991,057 | Majority: yes |
| The terms of office of the following directors continued after the Annual Meeting: Carolyn R. Bertozzi, M.D. | 106,783,262 | 6,133,628 | 29,162 | -- | 4,991,057 | Majority: yes |
| Proposal 3: The Company's stockholders ratified the appointment by the Company's Board of Directors of PricewaterhouseCoopers LLP as the Company's independent auditors for the fiscal year ending December 31, 2024. | 114,460,115 | 3,456,326 | 20,668 | -- | 0 | Majority: yes |
This meeting is also recorded here as 2024-05-17; both records come from the same filing, so the date should be checked against it.
Source: ALNYLAM PHARMACEUTICALS INC., Form 8-K, filed with the SEC on 2024-05-20 — read the filing on EDGAR.
Each item below shows how the 498 asset managers that disclosed a ALNYLAM PHARMACEUTICALS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of ALNYLAM PHARMACEUTICALS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 14 wordings of this item as funds reported it.
96% fund support · no official result
The 473 asset managers below cast 96% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 30,989,299 | 0 | 0 | 0 | For |
| Fidelity | 19,209,092 | 10,224 | 0 | 0 | For |
| Vanguard | 18,893,656 | 0 | 0 | 0 | For |
| T. Rowe Price | 10,859,507 | 172,484 | 0 | 0 | For |
| BlackRock | 7,808,059 | 0 | 0 | 0 | For |
| Wellington | 6,981,073 | 0 | 0 | 0 | For |
| Dodge & Cox | 6,395,131 | 0 | 0 | 0 | For |
| State Street | 3,336,882 | 0 | 0 | 0 | For |
| AMCAP FUND | 3,331,971 | 0 | 0 | 0 | For |
| Capital Research Global Investors | 3,136,845 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD & CO LTD | 2,426,931 | 0 | 0 | 0 | For |
| American Century | 0 | 2,152,115 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 1,987,575 | 0 | 0 | 0 | For |
| Man Group plc | 1,821,640 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD OVERSEAS LTD | 1,570,444 | 0 | 0 | 0 | For |
| JPMorgan | 1,043,587 | 0 | 0 | 0 | For |
| Charles Schwab | 944,210 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 888,487 | 0 | 0 | 0 | For |
| Northern Trust | 734,977 | 2,751 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 686,264 | 0 | 0 | 0 | For |
| Legal & General Investment Management Ltd | 0 | 617,424 | 0 | 0 | Against |
| Jackson National | 557,442 | 0 | 0 | 0 | For |
| Nuveen | 552,626 | 0 | 0 | 0 | For |
| TIAA | 539,618 | 0 | 0 | 0 | For |
| UBS | 0 | 521,780 | 0 | 0 | Against |
Showing the 25 largest of 473 asset managers. See all 473 in the interactive database.
Combines 8 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
ALNYLAM PHARMACEUTICALS INC.’s own tally for this item (“Proposal 3: The Company's stockholders ratified the appointment by the Company's Board of Directors of PricewaterhouseCoopers LLP as the Company's independent auditors for the fiscal year ending December 31, 2024.”): 114,460,115 for, 3,456,326 against, per its Form 8-K filed 2024-05-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 126,463,000 outstanding shares: 91% for, 3% against (93% of the company cast a for/against vote).
The 128 asset managers below cast 99.6% of the shares they voted on this item FOR (65,511,691 for, 223,603 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 18,597,294 | 0 | 0 | 0 | For |
| Capital Group | 14,436,051 | 0 | 0 | 0 | For |
| Fidelity | 9,412,385 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,521,656 | 0 | 0 | 0 | For |
| BlackRock | 3,341,538 | 0 | 0 | 0 | For |
| AMCAP FUND | 3,331,971 | 0 | 0 | 0 | For |
| Dodge & Cox | 2,854,341 | 0 | 0 | 0 | For |
| American Century | 1,028,316 | 0 | 0 | 0 | For |
| JPMorgan | 1,000,946 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 888,487 | 0 | 0 | 0 | For |
| State Street | 571,204 | 83 | 0 | 0 | For |
| Jackson National | 557,442 | 0 | 0 | 0 | For |
| TIAA | 539,348 | 0 | 0 | 0 | For |
| Charles Schwab | 442,624 | 0 | 0 | 0 | For |
| Equitable | 223,676 | 0 | 0 | 0 | For |
| First Trust | 219,863 | 0 | 0 | 0 | For |
| BNY Mellon | 206,703 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 194,004 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 192,539 | 0 | 0 | 0 | For |
| MassMutual | 189,127 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 174,015 | 0 | 0 | Against |
| John Hancock | 173,324 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 148,400 | 0 | 0 | 0 | For |
| Federated Hermes | 147,700 | 0 | 0 | 0 | For |
| Dimensional | 136,870 | 0 | 0 | 0 | For |
Showing the 25 largest of 128 asset managers. See all 128 in the interactive database.
Combines 7 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
ALNYLAM PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: David E.I. Pyott”): 102,273,209 for, 10,658,278 against, per its Form 8-K filed 2024-05-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 126,463,000 outstanding shares: 81% for, 8% against (89% of the company cast a for/against vote).
The 127 asset managers below cast 92% of the shares they voted on this item FOR (60,325,048 for, 5,409,246 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 18,597,294 | 0 | 0 | 0 | For |
| Capital Group | 14,436,051 | 0 | 0 | 0 | For |
| Fidelity | 9,412,385 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 4,521,656 | 0 | 0 | Against |
| BlackRock | 3,341,538 | 0 | 0 | 0 | For |
| AMCAP FUND | 3,331,971 | 0 | 0 | 0 | For |
| Dodge & Cox | 2,854,341 | 0 | 0 | 0 | For |
| American Century | 1,028,316 | 0 | 0 | 0 | For |
| JPMorgan | 1,000,946 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 888,487 | 0 | 0 | 0 | For |
| State Street | 571,157 | 130 | 0 | 0 | For |
| Jackson National | 306,432 | 251,010 | 0 | 0 | For |
| TIAA | 539,348 | 0 | 0 | 0 | For |
| Charles Schwab | 442,624 | 0 | 0 | 0 | For |
| Equitable | 172,037 | 51,639 | 0 | 0 | For |
| First Trust | 219,863 | 0 | 0 | 0 | For |
| BNY Mellon | 206,703 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 194,004 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 192,539 | 0 | 0 | 0 | For |
| MassMutual | 1,795 | 187,332 | 0 | 0 | Against |
| Aberdeen | 174,015 | 0 | 0 | 0 | For |
| John Hancock | 124,098 | 49,226 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 148,400 | 0 | 0 | 0 | For |
| Federated Hermes | 147,700 | 0 | 0 | 0 | For |
| Dimensional | 136,870 | 0 | 0 | 0 | For |
Showing the 25 largest of 127 asset managers. See all 127 in the interactive database.
Combines 7 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
ALNYLAM PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Dennis A. Ausiello, M.D.”): 103,971,532 for, 8,960,235 against, per its Form 8-K filed 2024-05-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 126,463,000 outstanding shares: 82% for, 7% against (89% of the company cast a for/against vote).
The 127 asset managers below cast 92% of the shares they voted on this item FOR (60,394,961 for, 5,339,333 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 18,597,294 | 0 | 0 | 0 | For |
| Capital Group | 14,436,051 | 0 | 0 | 0 | For |
| Fidelity | 9,412,385 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 4,521,656 | 0 | 0 | Against |
| BlackRock | 3,341,538 | 0 | 0 | 0 | For |
| AMCAP FUND | 3,331,971 | 0 | 0 | 0 | For |
| Dodge & Cox | 2,854,341 | 0 | 0 | 0 | For |
| American Century | 1,028,316 | 0 | 0 | 0 | For |
| JPMorgan | 1,000,946 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 888,487 | 0 | 0 | 0 | For |
| State Street | 571,074 | 213 | 0 | 0 | For |
| Jackson National | 306,432 | 251,010 | 0 | 0 | For |
| TIAA | 539,348 | 0 | 0 | 0 | For |
| Charles Schwab | 442,624 | 0 | 0 | 0 | For |
| Equitable | 172,037 | 51,639 | 0 | 0 | For |
| First Trust | 219,863 | 0 | 0 | 0 | For |
| BNY Mellon | 206,703 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 194,004 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 192,539 | 0 | 0 | 0 | For |
| MassMutual | 1,795 | 187,332 | 0 | 0 | Against |
| Aberdeen | 174,015 | 0 | 0 | 0 | For |
| John Hancock | 124,098 | 49,226 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 148,400 | 0 | 0 | 0 | For |
| Federated Hermes | 147,700 | 0 | 0 | 0 | For |
| Dimensional | 136,870 | 0 | 0 | 0 | For |
Showing the 25 largest of 127 asset managers. See all 127 in the interactive database.
Combines 7 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
ALNYLAM PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Olivier Brandicourt, M.D.”): 106,444,201 for, 6,487,472 against, per its Form 8-K filed 2024-05-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 126,463,000 outstanding shares: 84% for, 5% against (89% of the company cast a for/against vote).
The 127 asset managers below cast 95% of the shares they voted on this item FOR (62,517,004 for, 3,217,290 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 18,597,294 | 0 | 0 | 0 | For |
| Capital Group | 14,436,051 | 0 | 0 | 0 | For |
| Fidelity | 9,412,385 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,664,187 | 2,857,469 | 0 | 0 | Against |
| BlackRock | 3,341,538 | 0 | 0 | 0 | For |
| AMCAP FUND | 3,331,971 | 0 | 0 | 0 | For |
| Dodge & Cox | 2,854,341 | 0 | 0 | 0 | For |
| American Century | 1,028,316 | 0 | 0 | 0 | For |
| JPMorgan | 1,000,946 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 888,487 | 0 | 0 | 0 | For |
| State Street | 571,225 | 62 | 0 | 0 | For |
| Jackson National | 557,442 | 0 | 0 | 0 | For |
| TIAA | 539,348 | 0 | 0 | 0 | For |
| Charles Schwab | 442,624 | 0 | 0 | 0 | For |
| Equitable | 172,037 | 51,639 | 0 | 0 | For |
| First Trust | 219,863 | 0 | 0 | 0 | For |
| BNY Mellon | 14,353 | 192,350 | 0 | 0 | Against |
| OLD WESTBURY FUNDS INC | 194,004 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 192,539 | 0 | 0 | 0 | For |
| MassMutual | 189,127 | 0 | 0 | 0 | For |
| Aberdeen | 174,015 | 0 | 0 | 0 | For |
| John Hancock | 124,098 | 49,226 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 148,400 | 0 | 0 | 0 | For |
| Federated Hermes | 147,700 | 0 | 0 | 0 | For |
| Dimensional | 136,870 | 0 | 0 | 0 | For |
Showing the 25 largest of 127 asset managers. See all 127 in the interactive database.
Combines 7 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
ALNYLAM PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Peter N. Kellogg”): 108,577,015 for, 4,354,577 against, per its Form 8-K filed 2024-05-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 126,463,000 outstanding shares: 86% for, 3% against (89% of the company cast a for/against vote).
The 127 asset managers below cast 95% of the shares they voted on this item FOR (62,741,591 for, 2,992,703 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 18,597,294 | 0 | 0 | 0 | For |
| Capital Group | 14,436,051 | 0 | 0 | 0 | For |
| Fidelity | 9,412,385 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,664,187 | 2,857,469 | 0 | 0 | Against |
| BlackRock | 3,341,538 | 0 | 0 | 0 | For |
| AMCAP FUND | 3,331,971 | 0 | 0 | 0 | For |
| Dodge & Cox | 2,854,341 | 0 | 0 | 0 | For |
| American Century | 1,028,316 | 0 | 0 | 0 | For |
| JPMorgan | 1,000,946 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 888,487 | 0 | 0 | 0 | For |
| State Street | 571,225 | 62 | 0 | 0 | For |
| Jackson National | 557,442 | 0 | 0 | 0 | For |
| TIAA | 539,348 | 0 | 0 | 0 | For |
| Charles Schwab | 442,624 | 0 | 0 | 0 | For |
| Equitable | 172,037 | 51,639 | 0 | 0 | For |
| First Trust | 219,863 | 0 | 0 | 0 | For |
| BNY Mellon | 206,703 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 194,004 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 192,539 | 0 | 0 | 0 | For |
| MassMutual | 189,127 | 0 | 0 | 0 | For |
| Aberdeen | 174,015 | 0 | 0 | 0 | For |
| John Hancock | 124,098 | 49,226 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 148,400 | 0 | 0 | 0 | For |
| Federated Hermes | 147,700 | 0 | 0 | 0 | For |
| Dimensional | 136,870 | 0 | 0 | 0 | For |
Showing the 25 largest of 127 asset managers. See all 127 in the interactive database.
80% fund support · no official result
The 19 asset managers below cast 80% of the shares they voted on this item FOR (1,807,561 for, 455,392 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JPMorgan | 1,449,215 | 0 | 0 | 0 | For |
| Desjardins Global Asset Management Inc. | 0 | 392,352 | 0 | 0 | Against |
| APG Asset Management US Inc. | 103,434 | 0 | 0 | 0 | For |
| ANTIPODES PARTNERS Ltd | 84,068 | 0 | 0 | 0 | For |
| TOBAM | 73,797 | 0 | 0 | 0 | For |
| FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND | 27,415 | 0 | 0 | 0 | For |
| TD ASSET MANAGEMENT INC | 27,374 | 0 | 0 | 0 | For |
| EFG Asset Management (North America) Corp. | 20,150 | 0 | 0 | 0 | For |
| SECTOR GAMMA AS | 19,843 | 0 | 0 | 0 | For |
| Tredje AP-fonden | 0 | 19,791 | 0 | 0 | Against |
| Cardano Risk Management B.V. | 0 | 19,636 | 0 | 0 | Against |
| Regime de rentes du Mouvement Desjardins | 0 | 14,633 | 0 | 0 | Against |
| NORDEA INVESTMENT MANAGEMENT AB | 0 | 8,980 | 0 | 0 | Against |
| Symmetry Panoramic Trust | 471 | 0 | 673 | 0 | Abstain |
| OSSIAM | 1,105 | 0 | 0 | 0 | For |
| Virtus | 482 | 0 | 0 | 0 | For |
| ANDERSON HOAGLAND & CO | 104 | 0 | 0 | 0 | For |
| Milliman Variable Insurance Trust | 70 | 0 | 0 | 0 | For |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Ma | 33 | 0 | 0 | 0 | For |
Combines 2 wordings of this item as funds reported it.
97% fund support · no official result
The 2 asset managers below cast 97% of the shares they voted on this item FOR (11,600 for, 375 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Exome Asset Management LLC | 11,600 | 0 | 0 | 0 | For |
| NICHOLS & PRATT ADVISERS LLP /MA | 0 | 375 | 0 | 0 | Against |
Ranked by the number of ALNYLAM PHARMACEUTICALS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 126,463,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Capital Group | 24.50% |
| 2 | Fidelity | 15.20% |
| 3 | Vanguard | 14.94% |
| 4 | T. Rowe Price | 8.72% |
| 5 | BlackRock | 6.17% |
| 6 | Wellington | 5.52% |
| 7 | Dodge & Cox | 5.06% |
| 8 | State Street | 2.64% |
| 9 | AMCAP FUND | 2.63% |
| 10 | Capital Research Global Investors | 2.48% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| FMR (Fidelity) | 13.26% | 13F |
| Vanguard Group | 10.73% | 13F |
| BlackRock | 7.83% | 13F |
| Wellington Management | 5.70% | 13F |
| JPMorgan Chase | 3.59% | 13F |
| T. Rowe Price | 2.91% | 13F |
| Capital International | 2.89% | 13F |
| State Street | 2.52% | 13F |
| Geode Capital | 1.58% | 13F |
| Norges Bank | 1.20% | 13F |
Percentages above are of 126,463,000 shares outstanding, as reported by ALNYLAM PHARMACEUTICALS INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ALNYLAM PHARMACEUTICALS INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At ALNYLAM PHARMACEUTICALS INC.'s shareholder meeting held 2024-05-16, in the 2023-2024 proxy season, 498 asset managers reported how they voted in their SEC Form N-PX filings, covering 3,848 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. ALNYLAM PHARMACEUTICALS INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive… — the reporting funds cast 96% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.
ALNYLAM PHARMACEUTICALS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.